Establishment of a Tissue Sample Bank in the Field of Gynaecological Oncology
Recent progress in diagnosis and therapy of cancer diseases can be ascribed mainly to
translational research. The relevance of "translational oncology" will only increase in the
future -"From bench to bedside" - the swift implementation of new science research results
in clinical studies in order to expedite progress in clinical cancer therapy for the benefit
of the patient.
Its almost a matter of course in the medical science today to collect biological samples
together with clinical information thereby creating the foundation for future excellent
The aim of this tumor bank is to consist of biological samples (together with a blood bank -
see NCT01763125) and isolates of tumor patients and healthy people as controls. The
biological samples, the clinical date together with prospective experimental date constitute
the entity of the tumor bank. The content of the tumor bank can provide essential material
for current and future research (e.g. analyses of prognostic or predictive tumor markers;
genetically analysis (polymorphism, mutation, hypermethylation; verification and
characterisation of disseminated tumor cells).
Observational Model: Case Control
Establishment of blood/tissue bank consisting of oncological samples from cancer patients and benign and healthy controls.
Robert Zeillinger, Prof.Dr.
Medical University of Vienna, Dptm. of Obstetrics & Gynaecology